Document is current
Any future updates will be listed below
-
Authors
Brodaty, Henry https://orcid.org/0000-0001-9487-6617
Chau, Tiffany
Heffernan, Megan
Ginige, Jeewani A. https://orcid.org/0000-0002-6695-6983
Andrews, Gavin
Millard, Michael
Sachdev, Perminder S. https://orcid.org/0000-0002-9595-3220
Anstey, Kaarin J.
Lautenschlager, Nicola T. https://orcid.org/0000-0003-4850-7794
McNeil, John J. https://orcid.org/0000-0002-1049-5129
Jorm, Louisa
Kochan, Nicole A.
Maeder, Anthony https://orcid.org/0000-0002-7398-2581
Welberry, Heidi
San Jose, Juan Carlo
Briggs, Nancy E. https://orcid.org/0000-0002-1134-0807
Popovic, Gordana https://orcid.org/0000-0002-1376-1058
Mavros, Yorgi https://orcid.org/0000-0002-2588-0425
Almendrales Rangel, Carolina https://orcid.org/0000-0002-8664-563X
Noble, Yian
Radd-Vagenas, Sue https://orcid.org/0000-0001-8285-5819
Flood, Victoria M. https://orcid.org/0000-0001-5310-7221
O’Leary, Fiona
Lampit, Amit
Walton, Courtney C.
Barr, Polly
Fiatarone Singh, Maria
Valenzuela, Michael
- License Information
-
More Information
Article History
Received: 11 February 2024
Accepted: 10 October 2024
First Online: 28 January 2025
Competing interests
: H.B. has been an advisory board member or consultant to Biogen, Eisai, Eli Lilly, Medicines Australia, Roche, Skin2Neuron Pty, Cranbrook Care and Montefiore Homes. P.S.S. was a member of expert panels for Biogen and Roche in 2020 and 2021. M.V. has a financial interest in and is cofounder and CEO of Skin2Neuron Pty, unrelated to this work. The other authors declare no competing interests.
